India's Serum Institute expects approval for AstraZeneca vaccine in days | The Business Standard
Skip to main content
  • Latest
  • Epaper
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Thursday
June 19, 2025

Sign In
Subscribe
  • Latest
  • Epaper
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
THURSDAY, JUNE 19, 2025
India's Serum Institute expects approval for AstraZeneca vaccine in days

Coronavirus chronicle

Reuters
28 December, 2020, 06:30 pm
Last modified: 28 December, 2020, 06:33 pm

Related News

  • Bolsonaro home raided, phone seized in Brazil vaccine records probe
  • WHO provides 11 lakh bivalent vaccines to Bangladesh: Minister
  • Incepta Pharma abandons Covid vaccine plan
  • AstraZeneca, Moderna recipients to receive Pfizer vaccine to mix-and-match
  • Children aged 5-11 to get Covid jabs from 11 August

India's Serum Institute expects approval for AstraZeneca vaccine in days

“You will be hearing some good news from the UK very soon,” Serum’s Chief Executive Adar Poonawalla told reporters

Reuters
28 December, 2020, 06:30 pm
Last modified: 28 December, 2020, 06:33 pm
FILE PHOTO: An employee in personal protective equipment (PPE) removes vials of AstraZeneca's COVISHIELD, coronavirus disease (Covid-19) vaccine from a visual inspection machine inside a lab at Serum Institute of India, Pune, India, November 30, 2020. REUTERS/Francis Mascarenhas
FILE PHOTO: An employee in personal protective equipment (PPE) removes vials of AstraZeneca's COVISHIELD, coronavirus disease (Covid-19) vaccine from a visual inspection machine inside a lab at Serum Institute of India, Pune, India, November 30, 2020. REUTERS/Francis Mascarenhas

The Serum Institute of India, the local maker of the Oxford/AstraZeneca coronavirus vaccine, said on Monday it expected the British and Indian governments to approve shots for emergency use within a few days.

"You will be hearing some good news from the UK very soon," Serum's Chief Executive Adar Poonawalla told reporters, adding that approval from the Indian regulator would likely follow shortly.

"By January, we should have the AstraZeneca/Oxford vaccine licensed."

The Business Standard Google News Keep updated, follow The Business Standard's Google news channel

The company has already made 40 million to 50 million doses of the vaccine and will be able to ramp up capacity to around 100 million a month by March when a new facility comes online, Poonawalla said.

India wants to deliver 600 million coronavirus shots in the next six to eight months starting in January. The country's drug regulator is also considering similar approvals for the Pfizer/BioNTech vaccine and another developed by India's Bharat Biotech.

VACCINATION DRILLS

Some Indian states on Monday began a trial run of Covid-19 vaccine delivery systems, with health authorities checking everything from their technology platforms to the storage infrastructure that will be required to inoculate millions.

"The exercise is basically a mock drill for our healthcare workers on how to run the whole vaccination process and system," Jaiprakash Shivahare, the commissioner for health in the western state of Gujarat, told Reuters.

State health officials had set up 19 vaccination centres, each with 25 dummy beneficiaries played by health workers, who would help test out the entire inoculation sequence, including online monitoring systems, Shivahare said.

"The cold chain infrastructure for distribution of the vaccine is also being tested as a part of the dry run," he said.

India has the second-highest number of confirmed coronavirus cases in the world after the United States, and it has recorded 147,901 deaths so far.

On Monday, the federal health ministry reported a daily increase of a little over 20,000 infections, taking the country's total so far to 10.2 million cases.

World+Biz / South Asia

Serum Institute of India / covid-19 vaccine / AstraZeneca Covid-19 Vaccine

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Pvt sector's foreign loan rises by $454m on stable exchange rate, reserve in three months
    Pvt sector's foreign loan rises by $454m on stable exchange rate, reserve in three months
  • An anti-missile system operates as missiles are launched from Iran, as seen from Tel Aviv, Israel, 18 June 2025. Photo: Reuters
    Khamenei rejects Trump's demand for surrender, Trump says 'good luck'
  • Evacuation of Bangladeshis: Where do they go next from conflict-ridden Iran?
    Evacuation of Bangladeshis: Where do they go next from conflict-ridden Iran?

MOST VIEWED

  • Infograph: TBS
    Govt to ease loan rules to help foreign firms expand in Bangladesh
  • Google Pay. Photo: Collected
    Google Pay coming to Bangladesh next week
  • Logo of Beximco Group. Photo: Collected
    Beximco defaults on €33m in Germany, Deshbandhu owes Czech bank €4m
  • Global map showing nuclear weapon inventories by country as of January 2025, including deployed, stored, and retired warheads. Source: SIPRI
    How Israel's secret nuclear arsenal comes under spotlight amid attacks on Iran
  • The Kallyanpur Canal is burdened with more than 600,000 kilograms of waste every month. Photo: Courtesy
    Kallyanpur canal project shows how to combat plastic pollution in Dhaka
  • The India-Bangladesh integrated checkpost in Fulbari. Photo: Passang Yolmo via Telegraph India
    Import of boulders from Bhutan to Bangladesh stopped by Indian transporters in Fulbari

Related News

  • Bolsonaro home raided, phone seized in Brazil vaccine records probe
  • WHO provides 11 lakh bivalent vaccines to Bangladesh: Minister
  • Incepta Pharma abandons Covid vaccine plan
  • AstraZeneca, Moderna recipients to receive Pfizer vaccine to mix-and-match
  • Children aged 5-11 to get Covid jabs from 11 August

Features

Evacuation of Bangladeshis: Where do they go next from conflict-ridden Iran?

Evacuation of Bangladeshis: Where do they go next from conflict-ridden Iran?

7h | Panorama
The Kallyanpur Canal is burdened with more than 600,000 kilograms of waste every month. Photo: Courtesy

Kallyanpur canal project shows how to combat plastic pollution in Dhaka

1d | Panorama
The GLS600 overall has a curvaceous nature, with seamless blends across every panel. PHOTO: Arfin Kazi

Mercedes Maybach GLS600: Definitive Luxury

2d | Wheels
Renowned authors Imdadul Haque Milon, Mohit Kamal, and poet–children’s writer Rashed Rouf seen at Current Book Centre, alongside the store's proprietor, Shahin. Photo: Collected

From ‘Screen and Culture’ to ‘Current Book House’: Chattogram’s oldest surviving bookstore

3d | Panorama

More Videos from TBS

What's going on in Netanyahu's head behind the regime change story?

What's going on in Netanyahu's head behind the regime change story?

7h | TBS World
The type of bomb the US could use if Trump attacks Iran

The type of bomb the US could use if Trump attacks Iran

8h | TBS World
Why is Fordow Nuclear Facility at the Center of Trump’s Deliberations?

Why is Fordow Nuclear Facility at the Center of Trump’s Deliberations?

10h | TBS World
AI will replace jobs at tech giant: Amazon CEO

AI will replace jobs at tech giant: Amazon CEO

11h | Others
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net